Last reviewed · How we verify
Placebo for Inhalation
A placebo inhalation formulation that contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.
At a glance
| Generic name | Placebo for Inhalation |
|---|---|
| Sponsor | CanSino Biologics Inc. |
| Modality | Biologic |
| Phase | FDA-approved |
Mechanism of action
Placebos are inert substances used in randomized controlled trials to establish the true efficacy of an active drug by comparison. An inhalation placebo mimics the delivery route and administration procedure of an active inhaled therapy without providing any pharmacological effect, allowing researchers to distinguish genuine drug effects from placebo response and natural disease progression.
Approved indications
Common side effects
Key clinical trials
- SMILE Trial - Imaging Sub-Study
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record) (PHASE2)
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab (PHASE2)
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab (PHASE2)
- Evaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial (NA)
- JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart (PHASE2)
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (PHASE2)
- Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo for Inhalation CI brief — competitive landscape report
- Placebo for Inhalation updates RSS · CI watch RSS
- CanSino Biologics Inc. portfolio CI